Scpharmaceuticals

SCPH NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $6,102 $6,096 $3,796 $1,638
Gross Profit 4,266 4,323 2,717 1,284
EBITDA -15,805 -15,117 -14,839 -12,144
EBIT -15,856 -15,257 -15,111 -12,253
Net Income -14,108 -13,812 -15,634 -14,154
Net Change In Cash 6,102 6,096 3,796 1,638
Free Cash Flow -17,701 -15,195 -13,451 -14,144
Cash 58,447 46,814 35,042 71,350
Basic Shares 38,952 38,786 38,760 38,692

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $13,593 $2,063 $0 $0
Gross Profit 9,782 -468 -438 -399
EBITDA -54,770 -33,536 -25,459 -29,622
EBIT -55,396 -36,157 -25,823 -29,933
Net Income -54,810 -37,519 -30,486 -34,393
Net Change In Cash 13,593 2,063 0 0
Cost of Revenue -3,207 2,449 -805
Free Cash Flow -59,284 -34,598 -27,160 -27,693
Cash 46,814 71,061 74,268 105,277
Basic Shares 38,513 28,358 27,351 24,568

Earnings Calls

Quarter EPS
2024-03-31 -$0.36
2023-12-31 -$0.35
2023-09-30 -$0.41
2023-06-30 -$0.36